透明质酸钠与依克多因组合物在皮肤屏障修复中的应用
作者:
作者单位:

作者简介:

蔡丹(1989.11-),女,陕西商洛人,硕士,中级工程师,主要从事护肤品及医疗器械研发

通讯作者:

金柱(1991.3-),男,陕西汉中人,硕士,中级工程师,主要从事护肤品及医疗器械研发

中图分类号:

TQ464.7

基金项目:


Application of Composition of Sodium Hyaluronate and Ectoine in Skin Barrier Repair
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 通过不同评价方式探究透明质酸钠与依克多因组合物在皮肤屏障修复中的应用效果,并以 市售某透明质酸敷料做对照。方法 使用体外皮肤模型测定3种样品[皮肤屏障喷剂敷料(样品1)、皮肤屏 障修护敷料(样品2)、市售某透明质酸敷料(样品3)]对皮肤含水量的提升作用、对炎症因子及炎性介质的 抑制作用、对丝聚蛋白(FLG)及兜甲蛋白(LOR)分泌的促进作用。并对受试者进行人体双臂造模,比较 涂抹产品后经皮失水值(TEWL)变化。结果 样品组皮肤含水量显著高于空白对照组(P<0.01);样品1、 样品2、样品3的皮肤含水量提升率分别为73.05%、74.41%、84.06%。样品组IL-1α、TNF-α、PGE2含量低于 阴性对照组(P <0.05);样品1与样品2的IL-1α、PGE2含量低于样品3(P<0.05);样品1、样品2、样品3的 TNF-α含量比较,差异无统计学意义(P >0.05);样品1、样品2、样品3的IL-1α抑制率分别为25.11%、 43.40%、10.64%,TNF-α抑制率分别为28.25%、25.22%、33.41%,PGE2抑制率分别为37.21%、32.12%、 18.28%。样品组FLG、LOR含量显著高于阴性对照组(P <0.01);样品2的FLG、LOR含量显著高于样品 3(P <0.01);样品1、样品2、样品3的FLG提升率分别为92.31%、169.23%、76.92%,LOR提升率分别为 326.32%、384.21%、52.63%。样品1涂抹1、2、4 h时均对TEWL有抑制作用(P<0.05);样品2涂抹2 h时对 TEWL有抑制作用(P <0.05)。结论 透明质酸钠与依克多因组合物在皮肤屏障修复中展现出显著协同增 效作用,能够协同抑制IL-1α炎症因子及PGE2炎性介质的释放、促进FLG与LOR分泌,可从保湿、舒缓、 修护等方面改善皮肤屏障功能,为皮肤屏障损伤的干预与修复提供了新的思路。

    Abstract:

    Objective To explore the application effect of composition of sodium hyaluronate and ectoine in skin barrier repair through different evaluation methods, with a commercially available hyaluronic acid dressing as the control. Methods In vitro skin models were used to determine the effects of 3 samples [skin barrier spray dressing (Sample 1), skin barrier repair dressing (Sample 2) and a commercially available hyaluronic acid dressing (Sample 3)] on improving skin moisture content, inhibiting inflammatory factors and mediators, and promoting the secretion of filaggrin (FLG) and loricrin (LOR). A bilateral human forearm model was applied to the subjects to compare changes in transepidermal water loss (TEWL) after product application. Results The skin moisture content in the sample groups was significantly higher than that in the blank control group (P <0.01). The improvement rates of skin moisture content in Sample 1, Sample 2 and Sample 3 were 73.05%, 74.41% and 84.06% respectively. The contents of IL-1α, TNF-α and PGE2 in the sample groups were lower than those in the negative control group (P <0.05). The contents of IL-1α and PGE2 in Sample 1 and Sample 2 were lower than those in Sample 3 (P <0.05). There was no significant difference in TNF-α content among Sample 1, Sample 2 and Sample 3 (P >0.05). The inhibition rates of IL-1α in Sample 1, Sample 2 and Sample 3 were 25.11%, 43.40% and 10.64% respectively. The inhibition rates of TNF-α in Sample 1, Sample 2 and Sample 3 were 28.25%, 25.22%, and 33.41% respectively. The inhibition rates of PGE2 in Sample 1, Sample 2 and Sample 3 were 37.21%, 32.12%, and 18.28% respectively. The contents of FLG and LOR in the sample groups were significantly higher than those in the negative control group (P <0.01). The contents of FLG and LOR in Sample 2 were significantly higher than those in Sample 3 (P <0.01). The improvement rates of FLG in Sample 1, Sample 2 and Sample 3 were 92.31%, 169.23% and 76.92% respectively, and the improvement rates of LOR were 326.32%, 384.21%, and 52.63% respectively. Sample 1 inhibited TEWL at 1, 2, and 4 hours after application (P <0.05). Sample 2 inhibited TEWL at 2 hours after application (P <0.05). Conclusion The composition of sodium hyaluronate and ectoine shows a significant synergistic effect in skin barrier repair. It can synergistically inhibit the release of IL-1α inflammatory factor and PGE2 inflammatory mediator, promote the secretion of FLG and LOR, and improve skin barrier function in terms of moisturizing, soothing and repairing, providing a new idea for the intervention and repair of skin barrier damage.

    参考文献
    相似文献
    引证文献
引用本文

蔡 丹,吴田田,何璐骞,等.透明质酸钠与依克多因组合物在皮肤屏障修复中的应用[J].医学美学美容,2025,34(15):14-18.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-09-12
  • 出版日期: